These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Regional abnormalities of myocardial deformation in patients with hypertrophic cardiomyopathy: correlations with delayed enhancement in cardiac magnetic resonance. Ghio S; Revera M; Mori F; Klersy C; Raisaro A; Raineri C; Serio A; Pasotti M; Visconti LO Eur J Heart Fail; 2009 Oct; 11(10):952-7. PubMed ID: 19789398 [TBL] [Abstract][Full Text] [Related]
5. Myocardial scar as arrhythmia risk in patients with hypertrophic cardiomyopathy. Amado LC; Lima JA Curr Opin Cardiol; 2010 May; 25(3):276-81. PubMed ID: 20224393 [TBL] [Abstract][Full Text] [Related]
6. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699 [TBL] [Abstract][Full Text] [Related]
7. Scoring of late gadolinium enhancement in cardiac magnetic resonance imaging can predict cardiac events in patients with hypertrophic cardiomyopathy. Nojiri A; Hongo K; Kawai M; Komukai K; Sakuma T; Taniguchi I; Yoshimura M J Cardiol; 2011 Nov; 58(3):253-60. PubMed ID: 21890327 [TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging for hypertrophic cardiomyopathy update. Chan AK; Somarouthu B; Ghoshhajra B Top Magn Reson Imaging; 2014 Feb; 23(1):33-41. PubMed ID: 24509622 [TBL] [Abstract][Full Text] [Related]
9. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy. Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984 [TBL] [Abstract][Full Text] [Related]
10. Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy. Prinz C; Schwarz M; Ilic I; Laser KT; Lehmann R; Prinz EM; Bitter T; Vogt J; van Buuren F; Bogunovic N; Horstkotte D; Faber L Can J Cardiol; 2013 Mar; 29(3):358-63. PubMed ID: 22749647 [TBL] [Abstract][Full Text] [Related]
11. Delayed-enhancement MRI of apical hypertrophic cardiomyopathy: assessment of the intramural distribution and comparison with clinical symptoms, ventricular arrhythmias, and cine MRI. Amano Y; Takayama M; Fukushima Y; Kitamura M; Kumita S Acta Radiol; 2011 Jul; 52(6):613-8. PubMed ID: 21498307 [TBL] [Abstract][Full Text] [Related]
12. [Risk stratification in non ischemic cardiomyopathy: a case report--Case 5/2010]. Parade U; Klingel K; Kandolf R; Gawaz M; Schreieck J Dtsch Med Wochenschr; 2010 Jun; 135(22):1122. PubMed ID: 20514634 [TBL] [Abstract][Full Text] [Related]
13. Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging. Popović ZB; Kwon DH; Mishra M; Buakhamsri A; Greenberg NL; Thamilarasan M; Flamm SD; Thomas JD; Lever HM; Desai MY J Am Soc Echocardiogr; 2008 Dec; 21(12):1299-305. PubMed ID: 19041572 [TBL] [Abstract][Full Text] [Related]
14. Myocardial fibrosis and regional function in hypertrophic cardiomyopathy: may the force be with you. Carasso S; Rakowski H J Am Soc Echocardiogr; 2008 Dec; 21(12):1306-8. PubMed ID: 19041573 [No Abstract] [Full Text] [Related]
15. Risk stratification in hypertrophic cardiomyopathy: time for renewal? Pacileo G; Salerno G; Gravino R; Calabrò R; Elliott PM J Cardiovasc Med (Hagerstown); 2013 May; 14(5):319-25. PubMed ID: 22885536 [TBL] [Abstract][Full Text] [Related]
16. Aortic stiffness is increased in hypertrophic cardiomyopathy with myocardial fibrosis: novel insights in vascular function from magnetic resonance imaging. Boonyasirinant T; Rajiah P; Setser RM; Lieber ML; Lever HM; Desai MY; Flamm SD J Am Coll Cardiol; 2009 Jul; 54(3):255-62. PubMed ID: 19589439 [TBL] [Abstract][Full Text] [Related]
17. Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging. Olivotto I; Cecchi F; Poggesi C; Yacoub MH Circ Heart Fail; 2012 Jul; 5(4):535-46. PubMed ID: 22811549 [No Abstract] [Full Text] [Related]
18. Ischaemic and non-ischaemic cardiomyopathies--cardiac MRI appearances with delayed enhancement. Jackson E; Bellenger N; Seddon M; Harden S; Peebles C Clin Radiol; 2007 May; 62(5):395-403. PubMed ID: 17398263 [TBL] [Abstract][Full Text] [Related]
19. Left ventricular diastolic function assessed with cardiovascular magnetic resonance imaging and exercise capacity in patients with non-obstructive hypertrophic cardiomyopathy. Małek LA; Chojnowska L; Kłopotowski M; Misko J; Dabrowski M; Kuśmierczyk-Droszcz B; Maczyńska R; Piotrowicz E; Ruzyłło W Kardiol Pol; 2009 Jan; 67(1):1-6; discussion 7-8. PubMed ID: 19253184 [TBL] [Abstract][Full Text] [Related]
20. Hypertrophic cardiomyopathy: assessment with MR imaging and multidetector CT. Chun EJ; Choi SI; Jin KN; Kwag HJ; Kim YJ; Choi BW; Lee W; Park JH Radiographics; 2010 Sep; 30(5):1309-28. PubMed ID: 20833852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]